Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Journey Medical Corp - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
DERM
Nasdaq
2834
https://journeymedicalcorp.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Journey Medical Corp
Director Justin Smith Acquires 30,000 Shares of Journey Medical Corp (DERM)
- Mar 25th, 2024 11:01 pm
Journey Medical Full Year 2023 Earnings: EPS Misses Expectations
- Mar 23rd, 2024 12:52 pm
Q4 2023 Journey Medical Corp Earnings Call
- Mar 22nd, 2024 10:01 am
Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
- Mar 21st, 2024 8:01 pm
Journey Medical (DERM) Up as FDA Accepts Skin Disease Drug NDA
- Mar 19th, 2024 12:49 pm
Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea
- Mar 18th, 2024 12:30 pm
Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024
- Mar 15th, 2024 12:30 pm
Journey Medical Corporation to Participate in the 36th Annual ROTH Conference
- Mar 13th, 2024 12:30 pm
Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting
- Mar 11th, 2024 12:30 pm
Journey Medical Insiders Up US$187k On US$520.8k Investment
- Mar 8th, 2024 11:22 am
Journey Medical (DERM) to Report Q4 Earnings: What's in the Cards?
- Feb 26th, 2024 4:35 pm
Novo Nordisk (NVO) to Acquire 3 Catalent Sites for $11B
- Feb 5th, 2024 5:31 pm
Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat Rosacea
- Jan 5th, 2024 1:30 pm
Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 Million
- Jan 2nd, 2024 9:05 pm
Here's What Could Help Journey Medical Corporation (DERM) Maintain Its Recent Price Strength
- Dec 27th, 2023 1:50 pm
The Zacks Analyst Blog Highlights Amphastar Pharmaceuticals, Journey Medical, Centessa Pharmaceuticals and Aquestive Therapeutics
- Dec 27th, 2023 1:49 pm
What Awaits These 4 Drug Stocks That More Than Doubled in 2023?
- Dec 26th, 2023 2:29 pm
argenx (ARGX) Tanks on Top-Line Data From Pemphigus Study
- Dec 21st, 2023 2:50 pm
Anavex (AVXL) Rises as CHMP Deems Blarcamesine Eligible for MAA
- Dec 20th, 2023 4:09 pm
4 Drug Stocks Rising More Than 40% in 2023 With Room to Grow
- Dec 20th, 2023 1:45 pm
Scroll